Wake Forest Translational Alcohol Research Center (WF-TARC)
Project Number5P50AA026117-04
Contact PI/Project LeaderWEINER, JEFFREY L
Awardee OrganizationWAKE FOREST UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
PROJECT SUMMARY
The central goal of the Wake Forest Translational Alcohol Research Center (WF-TARC) is to employ animal
models and human subjects research to study behavioral and neurobiological substrates associated with
vulnerability (and resilience) to alcohol use disorder (AUD). This Center builds on a highly productive
translational alcohol research program at WFSM that was recently established with NIAAA developmental
program project (P01) support.
The WF-TARC will have four research projects and two cores. An administrative core will provide the
leadership and infrastructure needed to ensure integration across all research projects, provide biostatistical
support, and promote interactions and communication between this Center and the many other addiction-
related research and educational programs at Wake Forest School of Medicine (WFSM). A pilot project core
will be established to advance the goals and objectives of the WF-TARC. This core will fund four projects each
year to attract new investigators to bring their talent and expertise to the study of AUD vulnerability.
The unifying research focus of the WF-TARC will be to leverage the strengths and advantages of animal
models and human subjects research to study behavioral correlates of AUD vulnerability and identify
neurobiological adaptations that contribute to this heightened risk of developing AUD. Studies will employ
cutting-edge, multidisciplinary experimental approaches spanning molecular, cellular, circuit, and whole-brain
analyses. Importantly, each project will evaluate novel interventions targeted at the reversing the maladaptive
neural adaptations that promote AUD vulnerability. The highly-integrated conceptual framework and research
design will facilitate backward and forward interactions between the projects, facilitating the rapid translation of
therapeutic discoveries from animals to humans.
The WF-TARC takes advantage of a well-established, extremely collaborative translational alcohol research
program at WFSM and will benefit from a strong and growing institutional focus on alcohol and drug addiction
research. This Center will further enhance the outstanding educational environment at our institution, providing
unique training opportunities for the students and postdoctoral who will become the next generation of
translational alcohol researchers. Finally, the innovative research that will be supported by the WF-TARC may
lead to better evidence-based therapies for individuals who are at greatest risk of developing AUD, individuals
who are particularly ill-served by current AUD treatment options.
Public Health Relevance Statement
PROJECT NARRATIVE
The overarching research focus of the Wake Forest Translational Alcohol Research Center is to study
behavioral correlates associated with heightened vulnerability to alcohol use disorder and identify
neurobiological adaptations responsible for these behaviors. The highly integrated experimental design
leverages the unique benefits of rodent, non-human primate and human subjects research to facilitate
backward and forward translation between projects. Collectively, these studies may lead to novel therapeutic
interventions for individuals at greatest risk of developing alcohol use disorder.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AdolescenceAdolescentAlcohol consumptionAlcohol dependenceAlcoholismAlcoholsAnimal ModelAnimalsAnxietyBehaviorBiologicalBiometryBrainCessation of lifeChildhoodClinicalCommunicationCommunitiesDataDevelopmentDiagnosisDiseaseDrug AddictionEarly DiagnosisEnsureEnvironmentExperimental DesignsExperimental ModelsFacultyFundingGoalsGrantHealthcare SystemsHumanHuman Subject ResearchIndividualInfrastructureInstitutionInterdisciplinary StudyInterventionInvestmentsLeadLeadershipLearningLinkMethodsModelingMolecularMonkeysNational Institute on Alcohol Abuse and AlcoholismNeurobiologyPilot ProjectsPopulations at RiskPostdoctoral FellowPrevalencePublishingRelapseResearchResearch DesignResearch MethodologyResearch PersonnelResearch Project GrantsResistanceResourcesRiskRodentStudentsSubstance AddictionTalentsTherapeuticTherapeutic InterventionTrainingTranslational ResearchTranslationsUnited StatesVulnerable Populationsaddictionalcohol misusealcohol related problemalcohol researchalcohol use disorderbehavioral studycostcritical periodeducational atmosphereendophenotypeepidemiology studyevidence baseforesthuman modelinnovationmedical schoolsmultidisciplinaryneural circuitneuroadaptationneurobehavioralnext generationnonhuman primatenovelnovel therapeutic interventionproblem drinkerprogramsrecruitrelating to nervous systemresilienceresponsible alcohol usesocioeconomicsstressorsubstance usesuccesstherapeutically effectivetraining opportunity
National Institute on Alcohol Abuse and Alcoholism
CFDA Code
273
DUNS Number
937727907
UEI
SN7KD2UK7GC5
Project Start Date
10-December-2017
Project End Date
30-November-2022
Budget Start Date
01-December-2020
Budget End Date
30-November-2021
Project Funding Information for 2021
Total Funding
$1,602,773
Direct Costs
$1,272,811
Indirect Costs
$691,995
Year
Funding IC
FY Total Cost by IC
2021
National Institute on Alcohol Abuse and Alcoholism
$1,602,773
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P50AA026117-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P50AA026117-04
Patents
No Patents information available for 5P50AA026117-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P50AA026117-04
Clinical Studies
No Clinical Studies information available for 5P50AA026117-04
News and More
Related News Releases
No news release information available for 5P50AA026117-04
History
No Historical information available for 5P50AA026117-04
Similar Projects
No Similar Projects information available for 5P50AA026117-04